Have you ever wondered what’s in an mRNA vaccine? We have developed an RNA sequencing based test that measures mRNA vaccine quality on a single molecule level, in collaboration with BASE mRNA Facility and @GIH_UQ! Exciting times! Oxford Nanopore AIBN Research nature.com/articles/s4146…

Our research has been covered by Endpoints news! Read more about how we’re partnering with Oxford Nanopore and BASE mRNA Facility to develop a test of mRNA vaccine quality using Oxford Nanopore sequencing. A great outcome from our collaboration with @GIH_UQ. AIBN Research endpts.com/oxford-nanopor…

Thank you Oxford Nanopore! We’re excited to partner with you to transform mRNA vaccine quality analysis! BASE mRNA Facility

Real-time integrity measurement of individual #mRNA vaccine molecules is now possible thanks to a BASE mRNA Facility + Oxford Nanopore partnership. “Nanopore sequencing is the only sensing tech that can read native RNA in real time, making it an essential part of the toolkit" - Gordon Sanghera

VAX-seq offered a sensitive and quantitative assessment of mRNA characteristics, and also enabled real-time identification of antisense RNA and messenger RNA integrity, allowing for swift testing lasting a few hours post-manufacture. Read more: news-medical.net/news/20230922/…

Laura from the Seth Cheetham group and BASE mRNA Facility is newly initiated in making Oxford Nanopore cDNA sequencing libraries. Look at all that green from a >1 year old flow cell! Super impressive first libraries Laura!

A sequencing protocol with supporting software for quality assessment of mRNA vaccines @Mercerlab, BASE mRNA Facility and AIBN Research #BiotechNatureComms nature.com/articles/s4146…

BREAKING NEWS The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.

Long-read sequencing tools can capture the full picture of genomes and transcriptomes. An Analysis assesses the performance of long-read RNA sequencing analysis tools including isoform detection and differential expression analysis workflows. nature.com/articles/s4159…

For anyone after a Cliff notes version of our Oxford Nanopore sequencing test for mRNA vaccines made at BASE mRNA Facility, check out our “behind the paper” blog post.

Nature research paper: Genotyping, sequencing and analysis of 140,000 adults from Mexico City go.nature.com/45lE0UY

Last week, we welcomed Louise Talbot from the Department of Industry, Science, and Resources at #BASE mRNA Facility. We are delighted to demonstrate our advanced mRNA #manufacturing, ONT #sequencing tech for mRNA vaccines, and a #roundtable about mRNA research & innovation at UQ

Great to see an update on Oxford Nanopore only bacterial assemblies from Ryan Wick, using the latest base-caller models. tl/dr: use sup if you can afford it computationally.

Our Director A/Prof Tim Mercer talked about "mRNA Therapeutics’ Landscape" at The Bridge Program Symposium 2023. A lot of excitement in the mRNA space! #mRNA #therapeutics #manufacuring #innovation

We're at AusBiotech (1-3 Nov)! If you haven't talked to us yesterday, welcome to visit the BASE mRNA Facility Booth (#84). Looking forward to connecting and discussing the latest innovations in mRNA research and manufacture. #AusBiotech #mRNA #NonforProfit #ResearchService

Are you at #AusBiotech23 conference in Brisbane? Don't miss Today's (Friday 3rd Nov) session at 12:30 pm. BASE Deputy Director Seth Cheetham  will give a talk on "accelerated mRNA manufacture from synthetic DNA templates" at Breakout Room 1. See you soon!

A dedicated lab will produce mRNA for clinical trials AIBN Research's BASE facility. The next generation of mRNA vaccines and therapies will be built in Queensland, thanks to $4.3m from Australian Dept of Health, Disability and Ageing, #MRFF and contributions from #UQ Sanofi Queensland Government👏 More: uq.au/BASE

Thrilled at the announcement of our successful MRFF grant to establish mRNA manufacture BASE mRNA Facility for early-stage clinical trials of new mRNA vaccines and therapies. Thanks to Sanofi, UQ News and the Queensland Government for their support for this effort.

Exciting news! 🌟 BASE mRNA Facility, The University of Queensland, partners with Sanofi (TSH) and the Australian Government (MRFF) to advance #mRNA manufacturing for clinical trials, bolstering our capabilities to meet the surging demand. 💉🔬 stories.uq.edu.au/news/2023/uq-s…

BASE on the news! Check out the segment from @10NewsFirst on our recent clinical #mRNA manufacturing announcement featuring @Mercerlab